Antivenom Market Size, Share, Analysis and Forecast 2026
The Antivenom Market size was worth $XX billion in 2018 and is forecasted to reach $XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, October 16, 2019 ) Market Overview:
Antivenom is currently the mainstay of therapy for the venomous snakebites victims, which have reduced the mortality of this condition. As antivenom treatment being the only authorized treatment for snakebites with no other alternative options, it is giving opportunities for the key players to emerge in the Antivenom Market.
Market Dynamics:
Antivenom Market growth is driven by increasing government initiatives to promote the development of antivenom products of high quality, increased number of snakebites victims, recent FDA approvals of antivenom products, expanded research in developing high quality and advanced antivenom products.
Increasing government initiatives for the development of high-quality antivenom products and funds from non-profit organizations is expected to boost the market over the period of forecast.
However, withdrawal of antivenom products, high cost of products, stringent regulations, high cost for maintaining livestock for antivenom production are restraining the market.
Market Segmentation:
Based on type, the Antivenom Market is segmented into polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.
Polyvalent heterologous antivenoms segment is expected to boost the market over the period of forecast.
Based on species, the Antivenom Market is segmented into snakes, scorpions, spiders, and others. The Snakes segment is further segmented into common krait, common cobra, russell viper, and others.
Based on the mode of action, the Antivenom Market is segmented into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.
Based on end-users, the Antivenom Market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital's segment is expected to hold a significant share in the market.
Geographical Analysis:
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
North America is dominating the Antivenom Market in 2018 and estimated to hold the largest market size over the forecast period (2019-2026). This is owing to the abundance of snake population in the region, rising number of snakebites, FDA approvals and government initiatives for the development of high-quality antivenoms.
Competitive Analysis:
Some of the major players in the Antivenom Market are Pfizer, Merck, Haffkine Bio-Pharmaceutical Corporation Ltd, CSL Behring,Bharat Serums and Vaccines Ltd., Rare Therapeutics, Incepta vaccines Ltd and Vins Bioproducts Limited.
View full report: https://www.datamintelligence.com/research-report/antivenom-market
Download free sample: https://www.datamintelligence.com/download-sample/antivenom-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: pr@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Antivenom is currently the mainstay of therapy for the venomous snakebites victims, which have reduced the mortality of this condition. As antivenom treatment being the only authorized treatment for snakebites with no other alternative options, it is giving opportunities for the key players to emerge in the Antivenom Market.
Market Dynamics:
Antivenom Market growth is driven by increasing government initiatives to promote the development of antivenom products of high quality, increased number of snakebites victims, recent FDA approvals of antivenom products, expanded research in developing high quality and advanced antivenom products.
Increasing government initiatives for the development of high-quality antivenom products and funds from non-profit organizations is expected to boost the market over the period of forecast.
However, withdrawal of antivenom products, high cost of products, stringent regulations, high cost for maintaining livestock for antivenom production are restraining the market.
Market Segmentation:
Based on type, the Antivenom Market is segmented into polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.
Polyvalent heterologous antivenoms segment is expected to boost the market over the period of forecast.
Based on species, the Antivenom Market is segmented into snakes, scorpions, spiders, and others. The Snakes segment is further segmented into common krait, common cobra, russell viper, and others.
Based on the mode of action, the Antivenom Market is segmented into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.
Based on end-users, the Antivenom Market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital's segment is expected to hold a significant share in the market.
Geographical Analysis:
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
North America is dominating the Antivenom Market in 2018 and estimated to hold the largest market size over the forecast period (2019-2026). This is owing to the abundance of snake population in the region, rising number of snakebites, FDA approvals and government initiatives for the development of high-quality antivenoms.
Competitive Analysis:
Some of the major players in the Antivenom Market are Pfizer, Merck, Haffkine Bio-Pharmaceutical Corporation Ltd, CSL Behring,Bharat Serums and Vaccines Ltd., Rare Therapeutics, Incepta vaccines Ltd and Vins Bioproducts Limited.
View full report: https://www.datamintelligence.com/research-report/antivenom-market
Download free sample: https://www.datamintelligence.com/download-sample/antivenom-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: pr@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results